Search results
Results from the WOW.Com Content Network
Deficits in visuo-spatial, visual-motor, and visual memory functions are among the symptoms seen in post-chemotherapy patients. [28] There is evidence that this may be due to damage to the visual system rather than caused by cognitive deficits. In one study, 5-flouracil caused ocular toxicity in 25–38% of patients treated with the drug. [29]
Chemotherapy-induced acral erythema, also known as palmar-plantar erythrodysesthesia or hand-foot syndrome is reddening, swelling, numbness and desquamation (skin sloughing or peeling) on palms of the hands and soles of the feet (and, occasionally, on the knees, elbows, and elsewhere) that can occur after chemotherapy in patients with cancer.
Motor and autonomic symptoms are less frequent but possible. Symptoms may start days after the patient receives their first dose of chemotherapy, are dose dependent, and tend to improve after completion of treatment. However, in some cases, symptoms can persist six months or later following the completion of chemotherapy. [8]
Many chemotherapy symptoms are temporary, but it can take the body months, for some years, to recover from changes. ... After cancer treatment ends patients will also usually have check-ups and ...
Women undergoing chemotherapy for breast cancer, who also began an aerobic exercise program at the same time, reported significant improvements in both cognitive function and quality of life.
This occurs most commonly after the treatment of lymphomas and leukemias and in particular when treating non-Hodgkin lymphoma, acute myeloid leukemia, and acute lymphoblastic leukemia. [ 2 ] [ 3 ] This is a potentially fatal complication and people at an increased risk for TLS should be closely monitored while receiving chemotherapy and should ...
Me today, with my brother's dog, Ellie. Deanna Pai is a writer living in Manhattan. She was diagnosed with hepatoblastoma, a rare form of liver cancer, at the age of 23.
Delayed: occurring between 24 hours and 5 days after treatment; Breakthrough: occurring despite prophylactic treatment; Anticipatory: triggered by taste, odor, memories, visions, or anxiety related to chemotherapy; Refractory: occurring during subsequent cycles when antiemetics have failed in earlier cycles